MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
14.90
-0.10 (-0.67%)
At close: Dec 5, 2025, 4:00 PM EST
15.00
+0.10 (0.67%)
After-hours: Dec 5, 2025, 7:59 PM EST
MLTX Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -210.5 | -118.94 | -36.01 | -49.97 | -64.37 |
| Depreciation & Amortization | 2.23 | 1.38 | 0.37 | 0.16 | 0.01 |
| Asset Writedown & Restructuring Costs | - | - | - | - | 5.82 |
| Stock-Based Compensation | 11.24 | 7.28 | 7.11 | 9.65 | 10.86 |
| Other Operating Activities | -4.63 | -2.53 | -8.03 | -14.16 | 0.09 |
| Change in Accounts Receivable | -1.61 | -1.79 | -0.84 | -0.07 | -0.18 |
| Change in Accounts Payable | 14.57 | 7.15 | 1.58 | -1.31 | 1.88 |
| Change in Other Net Operating Assets | 3.01 | -9.15 | -6.96 | -0.2 | 3.68 |
| Operating Cash Flow | -185.69 | -116.59 | -42.78 | -55.89 | -42.21 |
| Capital Expenditures | -0.21 | -0.52 | -0.28 | -0.02 | -0.06 |
| Investment in Securities | 85.78 | -205.08 | -24.9 | -32.32 | - |
| Investing Cash Flow | 85.57 | -205.6 | -25.18 | -32.34 | -0.06 |
| Total Debt Issued | 73.02 | - | - | - | 18 |
| Short-Term Debt Repaid | - | - | - | -15 | - |
| Total Debt Repaid | - | - | - | -15 | - |
| Net Debt Issued (Repaid) | 73.02 | - | - | -15 | 18 |
| Issuance of Common Stock | 0.73 | 52.78 | 482.45 | 0.05 | 0.13 |
| Repurchase of Common Stock | -0 | -0 | - | - | -0.01 |
| Other Financing Activities | -0 | -1.47 | -2.75 | 134.65 | - |
| Financing Cash Flow | 73.75 | 51.31 | 479.7 | 119.69 | 51.92 |
| Foreign Exchange Rate Adjustments | 1.44 | 0.13 | -0.08 | 0.01 | 0 |
| Net Cash Flow | -24.92 | -270.74 | 411.66 | 31.47 | 9.65 |
| Free Cash Flow | -185.9 | -117.11 | -43.06 | -55.91 | -42.27 |
| Free Cash Flow Per Share | -2.94 | -1.86 | -0.88 | -1.90 | -5.39 |
| Cash Income Tax Paid | 0.21 | 0.15 | 0.04 | 0 | - |
| Levered Free Cash Flow | -117.38 | -92.06 | -24.14 | -32.23 | - |
| Unlevered Free Cash Flow | -114.1 | -92.06 | -24.14 | -32.23 | - |
| Change in Working Capital | 15.97 | -3.78 | -6.22 | -1.58 | 5.38 |
Source: S&P Capital IQ. Standard template.
Financial Sources.